fair prices ... s despite list prices that were within 1% of each other. Milliman suggests that clinical evidence may partly explain the differences in MFP between these drugs.

Drug price discounting is becoming more frequent and complex as industry and health care systems struggle to balance access and affordability. Leela Barham considers the pros and cons of keeping ...

US drug prices have soared over the last several decades, causing, at times, financial hardship for patients and their families, so Cuban says he developed MCCPDC with a simple mission – “to ...

India's drug pricing regulator has asked all retailers and dealers including online pharmacies to display the current price list of drugs on their website, in an attempt to empower consumers and make ...

Explore how Medicare drug price negotiations under the Inflation Reduction Act could evolve with the Trump administration. Read more here.

Many pharmaceutical companies face difficulties in securing the capital necessary to fund these endeavors, and the high cost of drug development often leads to high drug prices. Regulatory Barriers ...

The pharmaceutical industry fiercely opposes the price talks, arguing in a flurry of lawsuits that they threaten profits and discourage drug innovation. The Trump administration has offered few ...

Prices for brand-name drugs in the U.S. are three times what the same drugs cost in other countries. And in a recent KFF survey, 3 in 10 adults reported not taking their medicine as prescribed at some ...

Tariffs have the potential to "drive up drug prices," as "about half of generic drugs taken in the United States are made entirely overseas," said NBC News. Further, "China is increasingly playing ...

In 2025, seniors will pay less for 64 medications if they get them through Medicare Part B, which covers outpatient care, ...